Results 131 to 140 of about 5,407 (151)

Unusual Cutaneous Toxicity Following Treatment With Dactinomycin: A Report of Two Cases

Medical and Pediatric Oncology, 1995
Amar Gajjar, Vikramjit Kanwar, David Parham   +2 more
exaly  

Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2011
Azra Rabbani-Chadegani
exaly  

Severe acne and hyperandrogenemia following dactinomycin

Medical and Pediatric Oncology, 1993
J Blatt
exaly  

Dactinomycin in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group

Gynecologic Oncology, 1999
John A Blessing, Richard E Buller, D H Moore   +2 more
exaly  

Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia

Gynecologic Oncology, 2004
Ernst Lengyel, Lee-May Chen
exaly  

Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia

Cancer, 2006
Allan Covens, Virginia Filiaci, Raymond Osborne   +2 more
exaly  

Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel

Leukemia and Lymphoma, 2007
Staffan Eksborg, Eva Olah
exaly  

Dactinomycin

2002
Ines Mader, Patrizia Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, Sabine M. Wassertheurer   +5 more
openaire   +1 more source

Extravasation of dactinomycin, vincristine, and cisplatin: Studies in an animal model

Medical and Pediatric Oncology, 1985
G R Buchanan
exaly  

Selective inhibition by dactinomycin of NANC sensory bronchoconstriction and [125I] NKA binding due to NK‐2 receptor antagonism

Acta Physiologica Scandinavica, 1992
Y P Lou
exaly